# Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome

> **NCT00855972** · NA · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Low Dose Naltrexone

## Key facts

- **NCT ID:** NCT00855972
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-08
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The FDA IND application is paused due to additional required testing. The IRB protocol was closed prior to research starting.
- **Last updated:** 2015-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855972, "Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00855972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*